Evidence map›Paper›PMID 29531989›Full record

ArticleAddictive behaviors reports2015

Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?

Arvid Skutle, Eli Torild Hellandsjø Bu, Finn Konow Jellestad, Katelijne van Emmerik-van Oortmerssen, Geert Dom, Sofie Verspreet, Pieter Jan Carpentier, Josep Antoni Ramos-Quiroga, Johan Franck, Maija Konstenius and 16 more

Open access · goldAbstract read
In one paragraph

Article in Addictive behaviors reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 17 institutions in 10 countries.

Arvid SkutleBergen Clinics Foundation, Bergen, Norway.
Eli Torild Hellandsjø BuBergen Clinics Foundation, Bergen, Norway.
Finn Konow JellestadDepartment of Biological and Medical Psychology, University of Bergen, Norway.
Katelijne van Emmerik-van OortmerssenAmsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Geert DomCollaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium.
Sofie VerspreetCollaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium.
Pieter Jan CarpentierReinier van Arkel groep, 's-Hertogenbosch, The Netherlands.
Josep Antoni Ramos-QuirogaServei de Psiquiatria, Hospital Universitari Vall d'Hebron, CIBERSAM, Department of Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain.
Johan FranckDepartment of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
Maija KonsteniusDepartment of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
Sharlene KayeNational Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.
Zsolt DemetrovicsInstitute of Psychology, Eötvös Loránd University, Budapest, Hungary.
Csaba BartaInstitute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.
Melina FatséasLaboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France.
Marc AuriacombeLaboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France.
Brian JohnsonDepartment of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
Stephen V FaraoneDepartment of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
Frances R LevinColumbia University/the New York State Psychiatric Institute, New York, USA.
Steve AllsopNational Drug Research Institute/Curtin University of Technology, Perth, Australia.
Susan CarruthersNational Drug Research Institute/Curtin University of Technology, Perth, Australia.
Robert A SchoeversDept of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Maarten W J KoeterAmsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Wim van den BrinkAmsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Franz MoggiDepartment of Psychology, University of Fribourg, Fribourg, Switzerland.
Merete MøllerSykehuset Østfold, Norway.
Geurt van de GlindTrimbos Instituut, ICASA Foundation, The Netherlands.
Academic Medical Center · NLCurtin University · AUKarolinska Institutet · SESUNY Upstate Medical University · USUniversité de Bordeaux · FRUniversity of Antwerp · BEArkin · NLColumbia University · USEötvös Loránd University · HUØstfold Hospital Trust · NOReinier van Arkel · NLSemmelweis University · HUTrimbos Institute · NLUniversitat Autònoma de Barcelona · ESUniversity Medical Center Groningen · NLUniversity of Bergen · NOUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe prevalence of ADHD among patients with substance use disorder (SUD) is substantial. This study addressed the following research questions: Are early developmental, temperamental and educational problems overrepresented among SUD patients with ADHD compared to SUD patients without ADHD? Do this comorbid group receive early help for their ADHD, and are there signs of self-medicating with illicit central stimulants?

methodAn international, multi-centre cross-sectional study was carried out involving seven European countries, with 1205 patients in treatment for SUD. The mean age was 40 years and 27% of the sample was female. All participants were interviewed with the Mini International Neuropsychiatric Interview Plus and the Conners' Adult ADHD Diagnostic Interview for DSM-IV.

resultsSUD patients with ADHD (

conclusionThe results emphasize the importance of early identification of ADHD and targeted interventions in the health and school system, as well as in the addiction field.

Indexed as

ADHDDevelopmentalSubstance use disorderTemperamental and educational problems

Identifiers

PMID29531989
PMCPMC5845947
OpenAlexW2014262894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.